These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25697700)

  • 1. Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults.
    Donovan NJ; Hsu DC; Dagley AS; Schultz AP; Amariglio RE; Mormino EC; Okereke OI; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    J Alzheimers Dis; 2015; 46(1):63-73. PubMed ID: 25697700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults.
    Donovan NJ; Locascio JJ; Marshall GA; Gatchel J; Hanseeuw BJ; Rentz DM; Johnson KA; Sperling RA;
    Am J Psychiatry; 2018 Jun; 175(6):530-537. PubMed ID: 29325447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study.
    Gatchel JR; Donovan NJ; Locascio JJ; Schultz AP; Becker JA; Chhatwal J; Papp KV; Amariglio RE; Rentz DM; Blacker D; Sperling RA; Johnson KA; Marshall GA
    J Alzheimers Dis; 2017; 59(3):975-985. PubMed ID: 28697559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
    Wirth M; Villeneuve S; Haase CM; Madison CM; Oh H; Landau SM; Rabinovici GD; Jagust WJ
    JAMA Neurol; 2013 Dec; 70(12):1512-9. PubMed ID: 24166579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly.
    Wirth M; Oh H; Mormino EC; Markley C; Landau SM; Jagust WJ
    Alzheimers Dement; 2013 Nov; 9(6):687-698.e1. PubMed ID: 23474040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels.
    Babulal GM; Ghoshal N; Head D; Vernon EK; Holtzman DM; Benzinger TLS; Fagan AM; Morris JC; Roe CM
    Am J Geriatr Psychiatry; 2016 Nov; 24(11):1095-1104. PubMed ID: 27426238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.
    Wirth M; Madison CM; Rabinovici GD; Oh H; Landau SM; Jagust WJ
    J Neurosci; 2013 Mar; 33(13):5553-63. PubMed ID: 23536070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid Burden and Depressive Symptom Trajectories in Older Adults at Risk of Developing Cognitive Decline.
    Conejero I; Dubois J; Gutierrez LA; Delrieu J; Arbus C; Garcia M; Lopez-Castroman J; Courtet P; Gabelle A
    J Clin Psychiatry; 2021 Aug; 82(5):. PubMed ID: 34352166
    [No Abstract]   [Full Text] [Related]  

  • 11. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of the Rate of Change in Geriatric Depression Scale with Amyloid and Cerebral Glucose Metabolism in Cognitively Normal Older Adults: A Longitudinal Study.
    Wang ZT; Shen XN; Ma YH; Ou YN; Dong PQ; Tan PL; Yu PJ;
    J Affect Disord; 2021 Feb; 280(Pt A):77-84. PubMed ID: 33202341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease.
    Perin S; Harrington KD; Lim YY; Ellis K; Ames D; Pietrzak RH; Schembri A; Rainey-Smith S; Salvado O; Laws SM; Martins RN; Villemagne VL; Rowe CC; Masters CL; Maruff P;
    J Affect Disord; 2018 Mar; 229():269-274. PubMed ID: 29329059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults.
    Gatchel JR; Rabin JS; Buckley RF; Locascio JJ; Quiroz YT; Yang HS; Vannini P; Amariglio RE; Rentz DM; Properzi M; Donovan NJ; Blacker D; Johnson KA; Sperling RA; Marshall GA;
    JAMA Netw Open; 2019 Aug; 2(8):e198964. PubMed ID: 31397865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Kosaka J; Kudo T; Iida H; Kishimoto T; Nagatsuka K
    Int J Geriatr Psychiatry; 2016 Aug; 31(8):920-8. PubMed ID: 26766490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety and Depressive Symptoms and Cortical Amyloid-β Burden in Cognitively Unimpaired Older Adults.
    Lewis CK; Bernstein OM; Grill JD; Gillen DL; Sultzer DL
    J Prev Alzheimers Dis; 2022; 9(2):286-296. PubMed ID: 35543002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.
    Yau WW; Tudorascu DL; McDade EM; Ikonomovic S; James JA; Minhas D; Mowrey W; Sheu LK; Snitz BE; Weissfeld L; Gianaros PJ; Aizenstein HJ; Price JC; Mathis CA; Lopez OL; Klunk WE
    Lancet Neurol; 2015 Aug; 14(8):804-813. PubMed ID: 26139022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EEG evidence of compensatory mechanisms in preclinical Alzheimer's disease.
    Gaubert S; Raimondo F; Houot M; Corsi MC; Naccache L; Diego Sitt J; Hermann B; Oudiette D; Gagliardi G; Habert MO; Dubois B; De Vico Fallani F; Bakardjian H; Epelbaum S;
    Brain; 2019 Jul; 142(7):2096-2112. PubMed ID: 31211359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease.
    Gatchel JR; Donovan NJ; Locascio JJ; Becker JA; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
    Am J Geriatr Psychiatry; 2017 Jul; 25(7):683-693. PubMed ID: 28410856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.